Greater Philadelphia – Regional Life Sciences Roundup – October 15, 2026
Greater Philadelphia spent this week holding on to what it built. Across the send, the next step kept going to someone or something already close by: a board member moving into the CEO seat, a longtime partner becoming the parent company, a medtech product designed and built entirely in-house, and a new push to keep biotech manufacturing in the region instead of letting it leave once companies scale. It isn’t as flashy as a mega-round, but it’s what decides whether the region’s growth sticks.
A Philadelphia organization was tapped by the federal government to lead a new Mid-Atlantic effort to get young companies production-ready here, so the manufacturing and the jobs that come with it stay in the region. One of the world’s largest biopharma companies announced a major expansion in the Philadelphia suburbs, bringing manufacturing, R&D and quality together on a single site with a commitment to the people already working there. A Tokyo biotech chose Philadelphia for its first move outside Japan to take on one of cell therapy’s biggest hurdles: making these treatments at scale.
Leadership followed the same pattern. A Plymouth Meeting rare disease company named its next CEO from its own boardroom. Minaris Advanced Testing promoted Athenesia Faggins to lead quality and compliance after a career built across the region, from the lab bench to the director’s office.
Some deals grew out of long relationships, too. A Philadelphia digital pathology company is being acquired by the global life sciences company it first worked with as a partner years ago. A Malvern medtech company cleared the FDA with a surgical implant designed and built entirely by its own team.
Financial
Tracking the capital moving through Greater Philadelphia— funding rounds, M&A activity, and investment trends shaping Philadelphia, Southern New Jersey, and Delaware’s life sciences companies.
A Landmark Gift Sets Penn’s Heart Disease Research on a New Course
A major philanthropic gift is giving Penn Medicine a new home for some of the most ambitious work in heart health. The center will pair gene-editing science with clinical research, with the goal of going after the root causes of cardiovascular disease instead of managing its symptoms. Here’s what the new center plans to do and why the gift is a big moment for the region’s research community. Read More >
From Partner to Parent: A Philadelphia Pathology Company’s Next Chapter
A Philadelphia digital pathology company is about to become part of a global life sciences giant. The deal builds on a partnership that began years ago, and it signals how much weight AI-enabled pathology is carrying in diagnostics and drug discovery. Here’s what the acquisition means for the company and for the region’s growing health tech scene. Read More >
A New Funding Engine for Kids’ Health Is Taking Shape in the Mid-Atlantic
A landmark agreement is reshaping how one of the region’s best-known philanthropic legacies supports children’s health. It creates a new grantmaking arm that will direct funding to nonprofit programs for kids and families, while continuing support for a leading children’s health system. Read More >
People
Who we’re buzzing about this week — the leadership moves, board appointments, and rising names shaping the region’s life sciences community.
Meet the Women Shaping Health Tech From Greater Philadelphia and Beyond
A national recognition list celebrating women in health technology has named its 2026 class, and leaders from three of BioBuzz’s regions made the cut. The honorees range from clinicians and engineers to data and partnerships experts, and they’re helping shape how care is delivered and how health tech grows. Here’s who made the list and what their careers say about where the industry is headed. Read More >
From Board Seat to Corner Office: A Familiar Face Takes the Lead
A Plymouth Meeting rare disease company has named its next leader, tapping an executive who already knows the business from the inside. The incoming CEO brings experience from both large pharma and an early-stage biotech, and the change takes effect at the start of the new year. Here’s what the transition means for the company’s next phase. Read More >
Quality and Compliance Get a New Leader, and She’s Already Inside the Building
Athenesia Faggins, Ph.D., has been promoted to Director of Quality Assurance and Regulatory Compliance at Minaris Advanced Testing, a Navy Yard testing company. She brings nearly two decades of experience in cell and gene therapy and has built her career from the lab bench to the director’s office across several companies in the region. Read More >
What Do 3D-Printed Homes and Synthetic Tissues Have in Common?
Two researchers at the same Philadelphia university have won federal awards meant for bold, unconventional ideas, and the topics couldn’t be more different. One project looks at how the design of our homes shapes health, while the other focuses on building tissues from the cell level up to better model and treat disease. Here’s what each team plans to explore and why the funders are betting on them. Read More >
A CAR-T Builder Takes on Solid Tumors at a Global Pharma Company
Levi Gray-Rupp, Ph.D., has joined AstraZeneca as Global Product Leader, Solid Tumor Cell Therapy, based in Gaithersburg, Maryland. He brings more than a decade of experience in CAR-T discovery and early development, including taking a solid tumor CAR-T program from concept into the clinic. Read More >
Workforce
The hiring activity, team expansions, and talent trends driving growth across Philadelphia, New Jersey, and Delaware life sciences and biotech employers.
Want to Break Into AI Without Leaving Healthcare? These New Programs Aim to Help
A Philadelphia university is rolling out a new set of AI-focused programs aimed at the skills employers are asking for in health, life sciences, and data. The offerings range from full degrees to short certificates, with options for recent graduates, career changers, and professionals who want to keep working while they learn. Here’s a look at what’s on the menu and who each program is built for. Read More >
Have a Breakthrough, but No Business Plan? This Fellowship Wants to Meet You
A fellowship for scientists and engineers who want to take lab-built technology out into the world is now accepting applications for its 2027 cohort. It offers funding, hands-on mentorship, and a founder community built for researchers who’ve never started a company before. Applications close at the end of October, so here’s who it’s for and what it takes to apply. Apply Now >
Want a Career Beyond the Lab? This Free Program Shows You How
For scientists and early-career professionals, the path from research to a startup career can feel hard to find. This free program helps build it, pairing people from different backgrounds into teams and giving them hands-on training and mentorship from founders and investors across the industry. Applications are due soon, so here’s how it can help build the skills and connections for a career in biotech entrepreneurship. Apply Now >
Who’s hiring?!
Top Employer
Founded in Dublin, Ireland in 1990 with a small team of five, ICON now employs almost 40,000 people across 80 locations in 40+ countries, providing global expertise in clinical development and commercialization across a broad range of therapeutic areas. Having grown both organically and through strategic acquisitions, ICON has expanded its service portfolio and scaled its capabilities to become the world’s leading contract research organization, integrating experience, expertise, powerful technology solutions, AI, and data to deliver exceptional outcomes.
Grounded in four core values, Integrity, Collaboration, Agility, and Inclusion, ICON is expanding the possibilities of clinical research and delivering a better tomorrow for its customers, partners, and patients. With a strong presence across North America, the company continues to be a major driver of clinical research talent, offering roles spanning clinical operations, trial delivery, and country-level trial leadership
They are currently hiring across 300+ roles in the Greater Philadelphia region. Apply Now >
Other employers and available roles we’re paying attention to this week:
- Sanofi (Philadelphia, PA) is hiring a Strategic Account Manager | Apply Now >
- Madrigal Pharmaceuticals (Conshohocken, PA) is hiring an Associate Director Drug Product SME | Apply Now >
- Johnson & Johnson (Horsham, PA) is hiring an Associate Director, Customer Experience, Immunology | Apply Now >
- Immunocore (Randor, PA) is hiring a Director Safety Physician, Global Safety Lead | Apply Now >
- GSK (Philadelphia, PA) is hiring a Global Marketing Manager, Oncology| Apply Now >
Clinical + Commercial
The latest clinical trial progress, regulatory milestones, and commercial launches from companies advancing science from the lab to the market across Greater Philadelphia.
What If Your Medical Device Could Talk Back?
What if your medical device could talk back? A research team has built an AI-powered platform that lets patients chat with their devices through a smartphone app, asking questions, flagging symptoms, and getting feedback as things happen. The early results come from a small proof-of-concept study, but the researchers see it reaching far beyond the condition they started with. Here’s how it works and where the team hopes to take it next. Read More >
Can a New Approach Make Today’s Breast Cancer Drugs Work Better Together?
A Wilmington oncology company is teaming up with a global pharma leader to test an early-stage breast cancer drug alongside established treatments. The agreement is a clinical trial collaboration, and the company keeps full rights to its own drug. Here’s what the study will explore and why the company believes its approach could work well with the standard therapies already used for this type of breast cancer. Read More >
A Malvern Medtech Company Just Cleared the FDA With a Homegrown Product
A Malvern medtech company has cleared a major regulatory hurdle for a new surgical implant, and this one was designed and built entirely by its own team. The product is meant to give surgeons another option for reinforcing soft tissue, and it marks a milestone for how the company develops its technology. Read More >
Ecosystem
The partnerships, programs, and policy moves building Greater Philadelphia’s life sciences infrastructure — and the organizations driving it forward.
The New Mid-Atlantic Effort to Keep Biotech Manufacturing Close to Home
A Philadelphia organization has been tapped by the federal government to lead a new regional effort aimed at one of biotech’s toughest hurdles: turning promising science into products that can actually be made here in the U.S. The initiative reaches across several states and brings together partners focused on helping young companies get production-ready before they expand. Here’s how the new cluster plans to keep manufacturing, and the jobs that come with it, in the region. Read More >
Why a Tokyo Biotech Picked Philadelphia for Its First Move Abroad
A Tokyo biotech has chosen Philadelphia as its first stop outside Japan, setting up shop at a Philadelphia innovation hub to take on one of cell therapy’s biggest hurdles: making these treatments at scale. The company brings a technology designed to help cells stay healthier and more consistent as they’re grown, and it plans to work with developers and manufacturers across the region. Read More >
A Pharma Giant Just Made a Big Bet on the Philadelphia Suburbs
One of the world’s largest biopharma companies is doubling down on Pennsylvania with a major expansion in the Philadelphia suburbs. The plan brings manufacturing, R&D, and quality operations together on a single site, and it comes with new jobs and a commitment to the people already working here. Here’s what’s coming to the region and what it signals about Pennsylvania as a place to make medicines. Read More >
Other [Good] Reads
Editor’s picks from across the web — the stories, videos, and podcasts shaping the conversation in PHL biotech and life sciences this week.
Philadelphia discovers. Boston profits. That can change.
A new opinion column argues that Greater Philadelphia is a global leader in biomedical discovery but too often watches the biggest financial rewards land elsewhere. Using an unexpected comparison to the coffee trade, the author looks at where the region’s breakthroughs end up and what it would take to keep more of the value at home. Here’s the case for why the next chapter could look different. Read More >
CDMO roundtable: How can sponsors and CDMOs better align on timelines and IP expectations?
In cell and gene therapy, the timeline on the investor slide and the timeline in the manufacturing suite don’t always match. In this roundtable, leaders from across the contract manufacturing world weigh in on why that gap opens and what sponsors and their manufacturing partners can do to close it. They also take on a topic that often gets raised too late: who owns what. Here’s the advice they say can keep these partnerships on track. Read More >
Genome Editing Moves Personalized Therapy Closer to Reality
A personalized gene-editing treatment built in just months for a single infant at a Philadelphia hospital is now being held up as proof that the field is changing. In this article, experts from Brazil use that case to explain how newer editing tools work, what still stands in the way of getting these therapies to patients, and what families and clinicians should know right now. Read More >
On the Calendar
A few of the upcoming events, conferences, and networking opportunities across Greater Philadelphia’s life sciences ecosystem that you don’t want to miss.
Vendor Night
Thursday, October 15, 2026 • 5 – 8 PM • Malvern, PA
Hosted by Delaware Valley Chapter | Register Now >
Founders Alley: Our City in Motion
Tuesday, October 20, 2026 • 9 AM – 7 PM • Philadelphia, PA
Hosted by Pennovation Works | Register Now >
BioPharmaSpec Inc. Open Day
Thursday, October 22, 2026 • 4 – 7 PM • Malvern, PA
Hosted by BioPharmaSpec Inc. | Register Now >
Did we miss something!? Drop us a line →
Stay connected to Greater Philadelphia’s life sciences.
🔍 Explore companies → · 💼 Browse jobs → · 📅 See events → · 📰 Read more →
Get the Greater Philadelphia Region Roundup every Thursday.
The week’s most important life sciences news from PHL— delivered to your inbox.
